Article ; Online: Prevalence and clinical aspects of obstructive sleep apnea in Parkinson disease: A meta-analysis.
2023 Volume 31, Issue 2, Page(s) e16109
Abstract: Background and purpose: Obstructive sleep apnea (OSA) frequently occurs in Parkinson Disease (PD), probably caused by upper airway dysfunctions or shared pathogenetic mechanisms. OSA may precede PD diagnosis or worsen throughout its course, but its ... ...
| Abstract | Background and purpose: Obstructive sleep apnea (OSA) frequently occurs in Parkinson Disease (PD), probably caused by upper airway dysfunctions or shared pathogenetic mechanisms. OSA may precede PD diagnosis or worsen throughout its course, but its relationship with clinical features and dopaminergic medication remains unclear. This meta-analysis aimed to provide a reliable estimate of OSA prevalence in the PD population (PD-OSA) and to clarify its clinical associated factors to help clinicians in understanding the underlying pathophysiological mechanisms. Methods: A systematic literature search was performed up to April 2023 using the PubMed, Scopus, and PsycINFO databases. Articles were included if they provided data on PD patients with and without OSA. Pooled prevalence for PD-OSA was calculated using the proportions of PD participants diagnosed with OSA. Demographic and clinical features associated with PD-OSA were explored by comparing PD patients with and without OSA. Results: Seventeen studies were included in the meta-analysis. Pooled OSA prevalence was 45% of a total sample of 1448 PD patients and was associated with older age, male sex, higher body mass index (BMI), more severe motor disturbances and periodic limb movements, reduced risk of rapid eye movement sleep behavior disorder, intake of dopamine agonists, and worse excessive daytime sleepiness. No relationship emerged with cognitive functioning and neuropsychiatric manifestations. Conclusions: OSA affects nearly half of PD patients as a secondary outcome of predisposing factors such as older age and higher BMI in addition to PD-related motor impairment. Future studies should focus on determining the impact of both clinical features and dopaminergic medication on the development of PD-OSA. |
|---|---|
| MeSH term(s) | Humans ; Male ; Parkinson Disease/complications ; Parkinson Disease/epidemiology ; Polysomnography ; Prevalence ; REM Sleep Behavior Disorder/etiology ; REM Sleep Behavior Disorder/complications ; Sleep Apnea, Obstructive/epidemiology ; Sleep Apnea, Obstructive/complications |
| Language | English |
| Publishing date | 2023-11-03 |
| Publishing country | England |
| Document type | Journal Article ; Meta-Analysis ; Review ; Systematic Review |
| ZDB-ID | 1280785-0 |
| ISSN | 1468-1331 ; 1351-5101 ; 1471-0552 |
| ISSN (online) | 1468-1331 |
| ISSN | 1351-5101 ; 1471-0552 |
| DOI | 10.1111/ene.16109 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 4738: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
| Zs.MO 592: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.